# Major Recall Alert: Sodium Acetate Injection USP Recalled Due to Incorrect GTIN Code in the 2D Barcode
Omega Laboratories, a trusted name in pharmaceuticals, has issued an important recall for its Sodium Acetate Injection USP due to an error in the Global Trade Identification Number (GTIN) coded within the 2D data matrix barcode on the vial. This issue may cause potential challenges in product identification and traceability, making it vital for healthcare providers to act promptly. Stay informed with the latest updates and learn how to protect yourself below.
---
## Why This Recall is Important
Sodium Acetate Injection USP is an essential product used in the treatment and management of various medical conditions. With an incorrect GTIN in the 2D barcode, critical identification processes may be hindered between suppliers, healthcare providers, and pharmacists.
Such coding errors can disrupt inventory control systems, delay necessary treatments, and create potential risks in healthcare environments. Omega Laboratories urges affected parties to take immediate action to ensure patient safety and compliance with proper protocols.
### Key Highlights of the Recall:
- **Reason for Recall:** Incorrect Global Trade Identification Number (GTIN) in the 2D data matrix barcode on the vial.
- **Brand Name:** Omega Laboratories
- **Product:** Sodium Acetate Injection USP
- **Date Announced:** October 28, 2023
- **Source Link:** [Official Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/sodium-acetate-injection-usp-incorrect-gtin)
---
## Details of the Recall
In this case, the GTIN coded onto the vial’s 2D barcode does not match official product specifications. This discrepancy was identified during routine quality inspections conducted by Omega Laboratories.
The issue affects specific lots of Sodium Acetate Injection USP, though the manufacturer has not indicated any concerns with the product's quality, sterility, or performance. The recall is strictly a precautionary measure to address traceability concerns and ensure compliance with regulatory standards.
Consumers, distributors, and healthcare professionals are advised to cross-check their inventory to verify the GTIN details. If discrepancies are found, follow the recommended guidelines provided by Omega Laboratories to return or replace the affected lots.
For a detailed look at the affected product, view the official image here:
---
## What You Should Do
If you believe you may have received an affected vial of Sodium Acetate Injection USP, follow these steps:
1. **Verify the Barcode Details:** Check the GTIN on the vial against properly documented product labels.
2. **Stop Use Immediately:** Do not administer products that have mismatched GTIN codes. Set them aside in a secure place.
3. **Contact Omega Laboratories:** Report any impacted products to Omega Laboratories for further instructions on returns or replacement.
4. **Inform Healthcare Providers:** Alert all relevant parties, including pharmacists, distributors, and medical staff, to ensure the affected lots are removed from circulation.
Concerns regarding the recall can be directed to Omega Laboratories' customer support team for official advice and resolution.
---
## Stay Safe – Get Instant Recall Alerts
This latest recall emphasizes the importance of staying informed about product safety notifications that could impact you or your loved ones. The easiest way to stay ahead of recalls like this one is to download the My Recalls app.
With real-time notifications, detailed recall information, and resources for resolving product concerns, My Recalls is your go-to tool for safety.
**Download the app today and never miss a crucial recall update!**
---
**For more information on this recall, visit the official announcement here:** [Sodium Acetate Injection USP Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/sodium-acetate-injection-usp-incorrect-gtin)